U.S. market Closed. Opens in 14 hours 7 minutes

RNAC | Cartesian Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
Revenue26.00M110.78M85.08M16.60M6.68M903.00K207.00K8.08M6.01M3.04M
Cost of Revenue1.55M2.04MN/AN/AN/AN/AN/AN/AN/AN/A
Gross Profit24.45M108.74M85.08M16.60M6.68M903.00K207.00K8.08M6.01M3.04M
Operating Expenses110.87M96.24M89.67M73.42M57.10M64.95M63.24M41.95M30.27M18.44M
Selling, General & Admin40.58M23.86M20.94M18.91M14.36M17.26M18.08M12.25M7.29M7.95M
Research & Development71.84M72.38M68.74M54.51M42.74M47.69M45.16M29.70M22.98M10.49M
Other Operating ExpensesN/A330.00K15.00K89.00KN/AN/AN/AN/AN/AN/A
Operating Income-86.42M14.54M-4.60M-56.82M-52.45M-65.02M-63.78M-34.67M-25.30M-15.40M
Other Expenses / Income-152.29M20.23M-5.12M-12.05M-2.90M-314.00K-1.54M-1.54M130.00K2.52M
Before Tax Income-238.71M34.77M-9.72M-68.88M-55.35M-65.34M-65.32M-36.21M-25.17M-12.88M
Income Tax Expenses-19.00M-609.00K15.97M1.65M1.86M1.00N/AN/AN/AN/A
Net Income-219.71M35.38M-25.69M-68.88M-55.35M-65.34M-65.32M-36.21M-25.17M-12.88M
Interest Expenses2.83M3.03M2.84M1.56M1.52M1.49M1.21M1.25M948.00K552.00K
Basic Shares Outstanding5.17M4.83M3.81M3.37M1.52M746.31K680.83K349.80K621.65K428.95K
Diluted Shares Outstanding5.17M4.86M3.81M3.37M1.52M746.31K680.83K349.80K621.65K428.95K
EBITDA-235.06M39.84M-5.16M-65.59M-51.80M-62.87M-63.37M-34.16M-23.18M-11.46M
EBITDA Margin-903.95%35.96%-6.06%-395.21%-775.86%-6,962.02%-30,611.11%-422.55%-385.66%-377.11%
EBIT-235.88M37.80M-6.88M-65.67M-51.98M-63.84M-64.11M-34.96M-24.23M-12.33M
EBIT Margin-907.08%34.12%-8.08%-395.70%-778.43%-7,069.99%-30,973.43%-432.48%-403.03%-405.53%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙